Mirae Asset Global ETFs Holdings’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Buy
36,939
+11,135
+43% +$633K ﹤0.01% 1130
2026
Q1
$1.66M Buy
25,804
+847
+3% +$77.2K ﹤0.01% 1263
2025
Q4
$3.25M Sell
24,957
-348
-1% -$47.8K ﹤0.01% 951
2025
Q3
$2.73M Sell
25,305
-2,030
-7% -$221K ﹤0.01% 1008
2025
Q2
$2.52M Buy
27,335
+19,694
+258% +$1.55M ﹤0.01% 997
2025
Q1
$677K Buy
7,641
+453
+6% +$39.3K ﹤0.01% 1700
2024
Q4
$552K Buy
7,188
+515
+8% +$36K ﹤0.01% 1863
2024
Q3
$283K Buy
+6,673
New +$225K ﹤0.01% 2192

Other funds holding WGS

Mirae Asset Global ETFs Holdings's WGS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its GeneDx Holdings (WGS) stake by 43% in Q2 2026, buying an estimated $633K and bringing the position to 36,939 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

Mirae Asset Global ETFs Holdings first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.25M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 36,939 shares of GeneDx Holdings worth $2.54M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 11,135 GeneDx Holdings shares in Q2 2026, an estimated $633K.
  • GeneDx Holdings made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1130 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's GeneDx Holdings position peaked at $3.25M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.